| Literature DB >> 31778391 |
João Paulo Vieira Dos Santos1, Lucas Fabiano Garcia Leite2, Sheila Jorge Adad1, Mário-León Silva Vergara3, Adilha Misson Rua Micheletti1.
Abstract
Bronchoalveolar lavage, bronchial brushing and transbronchial biopsy are of fundamental importance in the diagnosis of pathologies affecting the lungs of immunosuppressed patients, especially those infected with HIV. This was a descriptive and retrospective study, in which the results of bronchoalveolar lavages, bronchial brushings and transbronchial biopsies of HIV-positive patients attended at the Clinical Hospital of the Federal University of Triangulo Mineiro from 1999 to 2015 were reviewed to determine the most frequent findings in these patients, to evaluate the diagnostic accuracy of these procedures and to correlate bronchoscopy results with clinical and radiological findings. Serological tests for HIV were confirmed and cases with negative or unverified serology were excluded. Medical records were reviewed for correlation with clinical and radiological findings. A total of 1,423 patients with a mean age of 50 years were initially selected; 727 cases had no serology for HIV; 696 had serology for HIV and 64 were positive. Of these, 47 were men, aged 24 to 84 years, and 17 women, aged 31 to 69 years. Biopsies and cytological tests were positive in 20 (31.25%) of the 64 patients and the most frequent diagnosis was pneumocystosis, found in 8 cases (12.5%). Of the 20 bronchofibroscopy-positive patients, only 2 did not show agreement between histopathological and clinical-radiological diagnoses. The analysis of the cytological tests and biopsy specimens obtained by bronchofibroscopy seems to be valuable for the etiological diagnosis of pulmonary infections in HIV- positive patients; however, negative results do not always exclude the diagnosis. In these cases, clinical symptoms and imaging findings may help to guide the best therapy.Entities:
Mesh:
Year: 2019 PMID: 31778391 PMCID: PMC6880975 DOI: 10.1590/S1678-9946201961061
Source DB: PubMed Journal: Rev Inst Med Trop Sao Paulo ISSN: 0036-4665 Impact factor: 1.846
Histopathological diagnosis by fiberoptic bronchoscopy in HIV-positive patients between 2006 and 2015 at HC-UFTM.
| Histopathological diagnosis | Number of cases (%) |
|---|---|
| Pneumocystis pneumonia | 8 (12.5) |
| Tuberculosis | 4 (6.25) |
| Nocardiosis | 3 (4.68) |
| Aspergillosis | 1 (1.56) |
| Cytomegalovirus | 1 (1.56) |
| Cryptococcosis | 1 (1.56) |
| Paracoccidioidomycosis | 1 (1.56) |
| Other mycobacterioses | 1 (1.56) |
| Negative tests | 44 (68.75) |
|
| |
|
|
|
Figure 1Photomicrographs of some frequent etiological agents in HIV patients: A) bronchoalveolar lavage fluid showing flocculent and intenseeosinophilic material suggestive of Pneumocystis jiroveci (HE, 400x); B) bronchoalveolar lavage fluid showing rounded, umbilicated and stacked silver-stained structures compatible with Pneumocystis jiroveci (Grocott, 400x); C) bronchoalveolar lavage fluid showing silver-stained filamentous bacteria compatible with Nocardia sp (Grocott, 400x); D) photomicroscopy of lung tissues showing frequent and large spores with multiple and small buds compatible with Paracoccidioides brasiliensis (Grocott, 400x).
- Positive bronchoscopy results in 20 HIV-positive patients according to clinical and radiological findings.
| Case | Sex | Age | Bronchoscopy | Clinical finding | Radiology |
|---|---|---|---|---|---|
| 1 | M | 56 | PCP | PCP | Perihilar opacity |
| 2 | F | 51 | Nocardiosis | Nocardiosis | Parenchymatous opacity |
| 3 | M | 60 | PCP | PCP | Parenchymatous opacity |
| 4 | M | 58 | PCP | PCP | Ground-glass opacity |
| 5 | M | 35 | TB | TB | Pleural effusion |
| 6 | M | 38 | PCP | PCP/Pneumonia/TB | Consolidation |
| 7 | M | 45 | PCP | PCP | Ground-glass attenuation |
| 8 | M | 37 | Cryptococcosis | TB/Abscess/Nocardiosis | Abscess/cavern |
| 9 | F | 69 | Mycobacteriosis | TB | Opacity/bronchiectasis |
| 10 | M | 44 | PCM | TB/Nocardia/Fungus | Parenchymatous opacity |
| 11 | M | 44 | Nocardiosis | TB/Nocardiosis/Histoplasmosis | No alterations |
| 12 | M | 45 | PCP | PCP | Ground-glass opacity |
| 13 | M | 33 | TB | TB/Fungal infection | Cavitations in apex |
| 14 | M | 50 | PCP | PCP | Nodules/consolidations |
| 15 | M | 59 | TB | TB/Histoplasmosis | Parenchymatous opacity |
| 16 | F | 72 | PCP | TB/PCM/PCP/Histoplasmosis | Reduction of soft parts |
| 17 | M | 63 | CMV | TB/KS/Aspergillosis | Hydropneumothorax |
| 18 | M | 84 | Aspergillus | TB/Pneumonia | Opacity/fungal ball |
| 19 | M | 43 | Nocardiosis | Histoplasmosis/Nocardiosis/TB | Parenchymatous opacity |
| 20 | M | 37 | TB | TB/Histoplasmosis | Parenchymatous opacity |
PCP: pneumocystis pneumonia; TB: tuberculosis; PCM: paracoccidioidomycosis; CMV: cytomegalovirus; KS: Kaposi’s sarcoma.